Antimycobacterial (Anti-tuberculosis Agent)
Aminosalicylic Acid (Para-aminosalicylic acid, PAS)
Brand names: Granupas
Adult dose
Dose: 8–12 g/day in 2–3 divided doses (usually 4 g sachets 2–3 times daily)
Route: Oral (granules dissolved in water, juice, or sprinkled on food)
Frequency: 2–3 times daily with meals
Clinical pearls
- Used for drug-resistant TB (MDR-TB and XDR-TB) as part of combination regimens
- Group C drug in WHO TB treatment classification for MDR-TB (2022 update)
- Granupas granules are enteric-coated — sprinkle on acidic foods (yoghurt, juice) to improve tolerability
- Do NOT use hot foods/drinks to dissolve (destroys the coating)
- Manage GI side effects with dose titration and administration with food
- Monitor thyroid function (hypothyroidism is common with prolonged use — treat with levothyroxine if needed)
Contraindications
- Severe renal impairment
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency (haemolysis risk)
- Hypersensitivity to salicylates
Side effects
- Gastrointestinal: nausea, vomiting, diarrhoea, abdominal pain (very common)
- Hypersensitivity reactions (fever, rash, hepatitis) — can be severe
- Hypothyroidism (inhibits thyroid hormone synthesis with prolonged use)
- Haemolytic anaemia (G6PD deficiency)
- Malabsorption of vitamin B12 and folate
Interactions
- Rifampicin — PAS delays absorption of rifampicin; separate administration by 8–12 hours
- Isoniazid — PAS may increase isoniazid toxicity
- Digoxin — reduced digoxin absorption
- Warfarin — PAS may enhance anticoagulant effect
- Probenecid — reduces renal elimination of PAS
Monitoring
- LFTs monthly
- Thyroid function (TSH) every 3–6 months
- Haemoglobin and reticulocytes (haemolysis)
- Vitamin B12 and folate levels
- Clinical response (sputum cultures, imaging)
Reference: BNF; NICE NG33 (Tuberculosis, 2016 updated 2023); WHO MDR-TB Guidelines (2022); BSAC/PHE TB guidelines; https://bnf.nice.org.uk/drugs/aminosalicylic-acid/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Tumor Lysis Syndrome Risk (Cairo-Bishop) · Oncological Emergency
- Mantoux Test / TST Interpretation (TB) · Tuberculosis
- TB Treatment Adherence Risk (DOTS Assessment) · Tuberculosis
- Rh(D) Immune Globulin Dosage for Maternal-Fetal Haemorrhage · Haematology in Pregnancy
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023